Hemostat Market in Korea 2020

1.1 Purpose
1.2 Utilization of Benefits
1.3 Scope
1.4 Market Segmentation
1.5 Definition
1.6 Research Method
1.6.1 Secondary Research
1.6.2 Primary Research
1.7 Analysis and Estimation Methods
1.7.1 Market Size Price Standard by Data Source
1.7.2 Exchange Rate
1.7.3 Market Size Estimation Methods
1.7.3.1 Reimbursement Size Estimation Methods

3.1 Total Market
3.1.1 5-Year Forecast
3.2 Use Volume of Hemostats by Medical Institutions
3.2.1 Total Hemostatic Products Market
3.2.2 Surgeries, Hemostatic Product Market
3.2.2.1 Hemostatic Product Market, By Medical Department
3.2.2.2 Hemostatic Product Market, By End User Type
3.2.3 Postoperative Vascular Intervention Hemostatic Product Market Product

4.1 Baxter
4.2 Hyundai Pharm
4.3 GC Pharma
4.4 Johnson & Johnson Medical Korea Ltd
4.5 Dalim Tissen Co.,Ltd
4.6 Hanmi Healthcare Inc
4.7 Samyang Biopharm
4.8 Bard Korea
4.9 Curesys
4.10 Nano Pharm
4.11 SK Plasma Co., Ltd.

5.1 Counter Healthcare Key Indicators
5.1.1 Historical Overview and Prospects for Market Development
5.1.2 Historical Overview of Payment Environment
5.1.3 Number of Medical institutions in Korea
5.1.4 Reimbursement and Non-Reimbursement Classifications of Hemostats
5.2 Recent Trends in Key Indicators of Hemostats Market Size
5.2.1 Aging Population
5.2.2 Number of Surgical Procedures
5.2.3 Number of Endoscopic Surgery
5.2.4 Robotic Surgery
5.2.5 Number of Cancer Patients
5.2.6 Trauma Center
5.2.7 Number of Foreign Patients
5.3 Market Drivers
5.3.1 Main Indicator
5.3.2 Supply
5.4 Opportunity
5.4.1 Increasing Demand due to Increase in Number of Surgeries
5.4.2 Coverage Expansion of National Health Insurance Policy
5.4.3 Hemostats with Innovative Features
5.4.4 Clinical Study on Hemostats Treatment Technology
5.5 Threat
5.5.1 Revaluation of Reimbursement Prices
5.5.2 Expansion of Diagnosis Related Group (DRG) and New Diagnosis Related Group (nDRG)
5.6 Unmet Needs